Synaptics (SYNA) Financials

$58.06 -0.56 (-0.96%)

Closing price 04:00 PM Eastern

Extended Trading

$57.16 -0.90 (-1.55%)

As of 07:29 PM Eastern

Annual Income Statements for Synaptics

This table shows Synaptics' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/28/2014	6/27/2015	6/25/2016	6/24/2017	6/30/2018	6/29/2019	6/27/2020	6/26/2021	6/25/2022	6/24/2023	6/29/2024
Net Income / (Loss) Attributable to Common Shareholders	47	110	72	49	-124	-23	119	80	258	74	126
Consolidated Net Income / (Loss)	47	110	72	49	-124	-23	119	80	258	74	126
Net Income / (Loss) Continuing Operations	47	110	72	49	-124	-23	119	80	258	74	126
Total Pre-Tax Income	75	160	76	61	-82	-21	159	120	321	126	-125
Total Operating Income	73	162	75	65	-62	-6.30	69	147	350	154	-102
Total Gross Profit	436	579	582	524	480	497	543	611	943	716	440
Total Revenue	948	1,703	1,667	1,718	1,630	1,472	1,334	1,340	1,740	1,355	959
Operating Revenue	948	1,703	1,667	1,718	1,630	1,472	1,334	1,340	1,740	1,355	959
Total Cost of Revenue	511	1,124	1,085	1,195	1,150	975	791	728	797	639	520
Operating Cost of Revenue	511	1,124	1,085	1,195	1,150	975	791	728	797	639	520
Total Operating Expenses	364	417	506	459	542	503	474	464	593	562	541
Selling, General & Admin Expense	100	128	162	138	154	131	127	145	168	175	161
Research & Development Expense	193	293	311	292	363	343	303	313	367	351	336
Amortization Expense	1.00	14	19	12	13	12	12	33	39	35	17
Impairment Charge	0.00	0.00	6.70	-	-	-	-	-	-	0.00	16
Restructuring Charge	0.00	0.00	8.60	7.30	12	18	33	7.40	18	0.00	11
Total Other Income / (Expense), net	2.00	-2.00	0.40	-3.40	-20	-15	91	-27	-30	-28	-23
Interest Expense	0.00	3.80	4.80	6.00	22	21	23	30	38	56	65
Interest & Investment Income	2.00	1.80	2.10	1.90	2.30	6.70	7.90	2.90	3.00	27	42
Income Tax Expense	28	50	3.40	12	41	0.30	39	31	65	52	-250
Other Gains / (Losses), net	-	0.00	0.00	-0.30	-1.80	-1.80	-2.00	-9.10	1.60	0.00	0.00
Basic Earnings per Share	$1.34	$2.99	$1.97	$1.40	($3.63)	($0.66)	$3.54	$2.29	$6.60	$1.86	$3.20
Weighted Average Basic Shares Outstanding	34.80M	36.90M	36.60M	34.80M	34.20M	34.60M	33.60M	34.80M	39M	39.60M	39.20M
Diluted Earnings per Share	$1.26	$2.84	$1.91	$1.37	($3.63)	($0.66)	$3.41	$2.08	$6.33	$1.83	$3.16
Weighted Average Diluted Shares Outstanding	37.10M	38.90M	37.90M	35.60M	34.20M	34.60M	34.80M	38.30M	40.70M	40.20M	39.70M
Weighted Average Basic & Diluted Shares Outstanding	34.90M	36.90M	36.60M	34.90M	34.20M	32.91M	34.23M	38.85M	39.63M	38.58M	39.58M

This table shows Synaptics' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/25/2022	9/24/2022	12/24/2022	3/25/2023	6/24/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024
Net Income / (Loss) Attributable to Common Shareholders	74	65	22	10	-23	-56	-9.00	-18	208	-23	1.80
Consolidated Net Income / (Loss)	83	65	22	10	-23	-56	-9.00	-18	208	-23	1.80
Net Income / (Loss) Continuing Operations	73	65	22	10	-23	-56	-9.00	-18	208	-23	1.80
Total Pre-Tax Income	115	104	39	27	-44	-41	-24	-23	-37	-34	-26
Total Operating Income	124	112	46	34	-38	-35	-18	-17	-31	-28	-15
Total Gross Profit	266	256	187	172	101	107	109	110	113	121	122
Total Revenue	476	448	353	327	227	238	237	237	247	258	267
Operating Revenue	476	448	353	327	227	238	237	237	247	258	267
Total Cost of Revenue	210	192	166	154	126	131	128	127	134	137	145
Operating Cost of Revenue	210	192	166	154	126	131	128	127	134	137	145
Total Operating Expenses	142	144	141	138	139	142	127	128	145	149	137
Selling, General & Admin Expense	38	45	42	42	46	42	40	41	39	50	50
Research & Development Expense	94	90	89	88	85	87	82	83	84	81	83
Amortization Expense	9.10	9.50	8.90	8.50	8.50	5.50	3.90	4.00	3.90	3.80	3.80
Restructuring Charge	0.50	0.00	0.00	0.00	-	8.00	1.30	-0.20	1.40	14	0.80
Total Other Income / (Expense), net	-17	-8.30	-6.70	-7.00	-6.30	-5.40	-6.10	-5.90	-5.60	-5.90	-11
Interest Expense	-	-	-	-	-	5.40	6.10	-	-	5.90	11
Income Tax Expense	32	39	17	17	-21	15	-15	-5.20	-245	-11	-28
Basic Earnings per Share	$2.13	$1.62	$0.55	$0.26	($0.57)	($1.43)	($0.23)	($0.46)	$5.32	($0.58)	$0.05
Weighted Average Basic Shares Outstanding	39M	39.80M	39.80M	39.40M	39.60M	38.80M	39.20M	39.30M	39.20M	39.80M	39.70M
Diluted Earnings per Share	$2.04	$1.59	$0.55	$0.26	($0.57)	($1.43)	($0.23)	($0.46)	$5.28	($0.58)	$0.05
Weighted Average Diluted Shares Outstanding	40.70M	40.70M	40.20M	39.90M	40.20M	38.80M	39.20M	39.30M	39.70M	39.80M	39.80M
Weighted Average Basic & Diluted Shares Outstanding	39.63M	39.87M	39.40M	39.52M	38.58M	39.20M	39.30M	39.50M	39.58M	40.06M	39.19M

This table details how cash moves in and out of Synaptics' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/28/2014	6/27/2015	6/25/2016	6/24/2017	6/30/2018	6/29/2019	6/27/2020	6/26/2021	6/25/2022	6/24/2023	6/29/2024
Net Change in Cash & Equivalents	92	-47	-48	16	-67	27	436	73	-12	101	-48
Net Cash From Operating Activities	132	204	257	153	145	154	222	319	463	332	136
Net Cash From Continuing Operating Activities	132	204	257	153	145	154	222	319	463	332	136
Net Income / (Loss) Continuing Operations	47	110	72	49	-124	-23	119	80	258	74	126
Consolidated Net Income / (Loss)	47	110	72	49	-124	-23	119	80	258	74	126
Depreciation Expense	14	25	31	33	39	36	27	22	24	27	28
Amortization Expense	7.40	88	74	61	102	93	70	148	124	130	82
Non-Cash Adjustments To Reconcile Net Income	32	35	71	60	73	56	-49	48	106	149	160
Changes in Operating Assets and Liabilities, net	32	-55	8.40	-49	55	-7.20	55	22	-49	-49	-259
Net Cash From Investing Activities	-58	-341	-27	-42	-439	-21	120	-523	-483	-6.00	-158
Net Cash From Continuing Investing Activities	-58	-341	-27	-42	-439	-21	120	-523	-483	-6.00	-158
Purchase of Property, Plant & Equipment	-39	-52	-29	-31	-34	-24	-16	-21	-31	-34	-34
Acquisitions	-20	-294	-4.60	-18	-404	0.00	-2.50	-627	-501	-16	-14
Purchase of Investments	-	0.00	0.00	-17	-	0.00	0.00	-5.00	-36	0.00	-137
Sale of Property, Plant & Equipment	-	-	-	-	0.00	0.00	139	0.00	56	0.10	0.00
Divestitures	-	-	-	-	-	-	0.00	0.00	5.00	0.00	0.00
Sale and/or Maturity of Investments	0.00	4.90	6.60	7.50	0.00	2.80	0.00	96	24	44	27
Net Cash From Financing Activities	19	94	-281	-94	227	-107	94	274	14	-221	-25
Net Cash From Continuing Financing Activities	19	94	-281	-94	227	-107	94	274	14	-221	-25
Repayment of Debt	-2.30	-4.20	-7.90	-20	-221	0.00	-0.70	-106	-11	-0.90	-4.10
Repurchase of Common Equity	-70	-121	-241	-88	-94	-119	-30	0.00	0.00	-184	0.00
Issuance of Debt	0.00	245	0.00	0.00	515	0.00	100	400	600	0.00	0.00
Issuance of Common Equity	81	49	32	25	32	21	35	28	15	18	16
Other Financing Activities, net	10	-3.20	-4.10	-5.50	-5.40	-9.40	-9.70	-48	-590	-55	-37
Effect of Exchange Rate Changes	0.00	-3.70	3.40	-0.90	0.00	0.10	0.00	2.20	-6.60	-3.50	-0.90
Cash Interest Paid	0.00	3.10	5.00	6.00	3.80	3.60	3.70	9.60	25	52	63

This table details how cash moves in and out of Synaptics' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/25/2022	9/24/2022	12/24/2022	3/25/2023	6/24/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024
Net Change in Cash & Equivalents	134	44	-49	79	27	-123	45	-18	49	-23	-258
Net Cash From Operating Activities	154	79	50	109	95	45	39	-14	65	-11	23
Net Cash From Continuing Operating Activities	154	79	50	109	95	45	39	-14	65	-11	23
Net Income / (Loss) Continuing Operations	83	65	22	10	-23	-56	-9.00	-18	208	-23	1.80
Consolidated Net Income / (Loss)	83	65	22	10	-23	-56	-9.00	-18	208	-23	1.80
Depreciation Expense	6.10	6.20	6.40	7.60	7.20	7.20	6.80	6.80	6.80	7.20	7.40
Amortization Expense	14	33	32	32	33	23	18	18	22	25	25
Non-Cash Adjustments To Reconcile Net Income	43	36	39	38	38	46	34	34	46	31	44
Changes in Operating Assets and Liabilities, net	8.20	-61	-49	21	40	25	-11	-55	-218	-51	-55
Net Cash From Investing Activities	-13	2.30	-21	-9.30	22	-150	10	-6.90	-11	-9.10	-5.50
Net Cash From Continuing Investing Activities	-13	2.30	-21	-9.30	22	-150	10	-6.90	-11	-9.10	-5.50
Purchase of Property, Plant & Equipment	-4.20	-6.20	-9.10	-14	-5.20	-6.70	-10	-9.00	-7.70	-9.10	-4.70
Acquisitions	3.70	0.00	-16	-	0.90	-14	-	-	-	0.00	-0.80
Net Cash From Financing Activities	-2.60	-35	-80	-19	-87	-18	-5.80	3.50	-4.70	-3.50	-275
Net Cash From Continuing Financing Activities	-2.60	-35	-80	-19	-87	-18	-5.80	3.50	-4.70	-3.50	-275
Repayment of Debt	1.30	1.30	-1.50	0.70	-1.40	-1.30	-1.50	0.20	-1.50	0.10	-587
Other Financing Activities, net	-4.00	-31	-18	-3.10	-2.30	-25	-4.30	-4.10	-3.20	-11	-53
Effect of Exchange Rate Changes	-4.70	-2.00	2.10	-0.80	-2.80	-0.60	1.10	-0.90	-0.50	0.70	-0.10

This table presents Synaptics' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/28/2014	6/27/2015	6/25/2016	6/24/2017	6/30/2018	6/29/2019	6/27/2020	6/26/2021	6/25/2022	6/24/2023	6/29/2024
Total Assets	1,020	1,519	1,300	1,267	1,500	1,410	1,694	2,227	2,858	2,611	2,825
Total Current Assets	743	916	780	792	740	731	1,078	1,180	1,403	1,272	1,162
Cash & Equivalents	447	400	352	368	301	328	763	836	824	925	877
Accounts Receivable	195	325	253	255	289	230	195	228	322	164	142
Inventories, net	82	140	146	131	131	159	102	82	170	137	114
Prepaid Expenses	18	51	29	38	18	15	17	33	36	37	29
Plant, Property, & Equipment, net	81	123	113	114	118	103	84	91	63	66	76
Total Noncurrent Assets	197	480	407	361	643	576	532	956	1,392	1,273	1,587
Goodwill	61	207	207	207	373	373	361	570	807	816	816
Intangible Assets	82	235	160	101	219	145	93	302	390	299	288
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	-	-	68	346
Other Noncurrent Operating Assets	54	38	40	53	51	58	78	84	195	90	137
Total Liabilities & Shareholders' Equity	1,020	1,519	1,300	1,267	1,500	1,410	1,694	2,227	2,858	0.00	2,825
Total Liabilities	319	726	595	527	771	753	875	1,260	1,592	1,368	1,358
Total Current Liabilities	254	447	351	310	284	254	244	787	463	260	277
Short-Term Debt	0.00	11	19	15	-	-	0.00	0.00	6.00	6.00	6.00
Accounts Payable	97	189	173	136	157	98	61	98	142	46	88
Accrued Expenses	57	74	82	102	80	106	91	96	145	99	156
Current Employee Benefit Liabilities	31	36	40	32	25	30	60	76	91	46	27
Total Noncurrent Liabilities	65	280	244	216	487	499	631	473	1,128	1,108	1,081
Long-Term Debt	0.00	231	217	202	451	468	587	394	976	972	967
Other Noncurrent Operating Liabilities	65	15	19	14	36	30	44	79	153	136	114
Total Equity & Noncontrolling Interests	701	793	705	740	729	657	819	967	1,266	1,243	1,467
Total Preferred & Common Equity	701	793	705	740	729	657	819	967	1,266	1,243	1,467
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Common Equity	701	793	705	740	729	657	819	967	1,266	1,243	1,467
Common Stock	740	844	929	1,005	1,195	1,266	1,340	1,392	924	1,009	1,107
Retained Earnings	483	593	665	714	606	584	701	781	1,039	1,112	1,238
Treasury Stock	-530	-652	-892	-980	-1,074	-1,192	-1,223	-1,205	-695	-878	-878

This table presents Synaptics' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025
Period end date	3/26/2022	9/24/2022	12/24/2022	3/25/2023	9/30/2023	12/30/2023	3/30/2024	9/28/2024	12/28/2024
Total Assets	2,698	2,825	2,725	2,715	2,549	2,573	2,540	2,791	2,528
Total Current Assets	1,247	1,412	1,324	1,334	1,109	1,147	1,123	1,140	891
Cash & Equivalents	690	868	819	898	801	846	828	854	596
Accounts Receivable	298	284	255	218	111	127	145	136	147
Inventories, net	146	179	178	148	132	125	114	120	120
Prepaid Expenses	48	37	33	34	41	47	35	31	28
Plant, Property, & Equipment, net	63	63	66	69	67	71	74	80	75
Total Noncurrent Assets	1,388	1,350	1,335	1,311	1,373	1,355	1,343	1,572	1,562
Goodwill	815	807	816	816	816	816	816	816	820
Intangible Assets	410	357	334	331	289	270	252	264	242
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	-	-	358	369
Other Noncurrent Operating Assets	164	186	185	164	268	268	275	133	131
Total Liabilities & Shareholders' Equity	2,698	2,825	2,725	2,715	2,549	2,573	2,540	2,791	2,528
Total Liabilities	1,540	1,500	1,425	1,394	1,344	1,353	1,304	1,324	1,151
Total Current Liabilities	393	365	299	269	246	253	211	254	230
Short-Term Debt	0.00	6.00	6.00	6.00	6.00	6.00	6.00	6.00	0.00
Accounts Payable	136	125	83	61	64	83	71	83	84
Accrued Expenses	139	128	113	94	103	104	99	136	115
Current Employee Benefit Liabilities	80	52	37	44	24	22	26	28	31
Total Noncurrent Liabilities	1,147	1,134	1,126	1,125	1,099	1,100	1,093	1,070	922
Long-Term Debt	983	975	974	973	970	969	968	966	833
Other Noncurrent Operating Liabilities	165	160	152	152	129	131	126	104	89
Total Equity & Noncontrolling Interests	1,158	1,325	1,300	1,321	1,204	1,220	1,235	1,467	1,376
Total Preferred & Common Equity	1,158	1,325	1,300	1,321	1,204	1,220	1,235	1,467	1,376
Preferred Stock	-	-	-	-	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,158	1,325	1,300	1,321	1,204	1,220	1,235	1,467	1,376
Common Stock	898	932	946	981	1,026	1,051	1,084	1,131	1,112
Retained Earnings	956	1,103	1,125	1,136	1,057	1,048	1,029	1,215	1,216
Treasury Stock	-695	-708	-769	-795	-878	-878	-878	-878	-953

This table displays calculated financial ratios and metrics derived from Synaptics' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	6/28/2014	6/27/2015	6/25/2016	6/24/2017	6/30/2018	6/29/2019	6/27/2020	6/26/2021	6/25/2022	6/24/2023	6/29/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	42.78%	79.74%	-2.12%	3.08%	-5.12%	-9.70%	-9.39%	0.43%	29.87%	-22.11%	-29.20%
EBITDA Growth	-15.61%	192.67%	-33.37%	-13.30%	-50.09%	53.40%	122.50%	16.72%	59.12%	-37.99%	-97.56%
EBIT Growth	-28.00%	123.72%	-51.73%	-16.48%	-194.65%	89.82%	2,861.90%	-15.52%	142.04%	-56.63%	-165.85%
NOPAT Growth	-53.59%	145.96%	-35.75%	-27.84%	-183.61%	89.82%	1,284.02%	107.92%	157.70%	-67.78%	-178.91%
Net Income Growth	-52.78%	136.40%	-34.60%	-32.41%	-354.30%	81.55%	618.78%	-33.00%	223.49%	-71.42%	70.65%
EPS Growth	-56.40%	125.40%	-32.75%	-28.27%	-364.96%	81.82%	616.67%	-39.00%	204.33%	-71.09%	72.68%
Operating Cash Flow Growth	28.89%	55.09%	25.72%	-40.41%	-5.17%	6.34%	43.84%	43.91%	44.96%	-28.36%	-59.00%
Free Cash Flow Firm Growth	-328.41%	-376.16%	144.15%	-57.42%	-756.36%	123.06%	170.50%	8.59%	-351.38%	130.89%	-298.03%
Invested Capital Growth	67.23%	150.24%	-7.44%	0.19%	49.13%	-9.24%	-19.49%	-18.22%	161.20%	-6.19%	21.42%
Revenue Q/Q Growth	9.81%	10.66%	-8.51%	6.35%	-2.28%	-5.97%	-1.30%	3.89%	9.34%	-15.53%	2.14%
EBITDA Q/Q Growth	-10.25%	9.91%	-26.78%	32.25%	0.00%	-22.32%	104.99%	-8.77%	10.01%	-30.69%	-38.71%
EBIT Q/Q Growth	-16.58%	2.94%	-45.70%	174.79%	-28.69%	-127.16%	601.61%	-28.22%	26.17%	-50.66%	6.36%
NOPAT Q/Q Growth	-19.34%	-1.91%	-35.83%	110.84%	-75.85%	-103.38%	249.24%	25.03%	24.83%	-54.79%	6.36%
Net Income Q/Q Growth	-18.79%	-2.80%	-34.72%	104.18%	-18.42%	-205.05%	782.76%	-47.49%	33.70%	-59.09%	218.38%
EPS Q/Q Growth	-24.55%	-3.73%	-33.68%	98.55%	-16.72%	-203.13%	810.42%	-50.48%	33.54%	-58.78%	217.47%
Operating Cash Flow Q/Q Growth	6.48%	-4.18%	46.63%	-29.77%	-21.83%	29.91%	4.77%	19.19%	11.95%	-15.28%	-17.84%
Free Cash Flow Firm Q/Q Growth	-55.08%	3.35%	27.14%	-19.84%	-13.85%	-37.37%	64.18%	180.66%	-532.96%	-19.91%	-283.86%
Invested Capital Q/Q Growth	16.22%	3.91%	-6.60%	-0.30%	2.33%	-7.95%	-8.92%	-50.98%	-0.96%	-5.78%	13.21%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.03%	33.98%	34.89%	30.47%	29.45%	33.77%	40.72%	45.63%	54.21%	52.83%	45.84%
EBITDA Margin	9.93%	16.17%	11.01%	9.26%	4.87%	8.27%	20.32%	23.61%	28.93%	23.03%	0.79%
Operating Margin	7.65%	9.52%	4.51%	3.77%	-3.80%	-0.43%	5.17%	10.97%	20.14%	11.39%	-10.59%
EBIT Margin	7.65%	9.52%	4.70%	3.81%	-3.80%	-0.43%	13.04%	10.97%	20.45%	11.39%	-10.59%
Profit (Net Income) Margin	4.93%	6.48%	4.33%	2.84%	-7.61%	-1.56%	8.91%	5.94%	14.80%	5.43%	13.09%
Tax Burden Percent	62.68%	68.91%	95.50%	79.61%	151.71%	110.10%	74.53%	66.28%	80.34%	58.41%	-100.80%
Interest Burden Percent	102.76%	98.77%	96.55%	93.73%	132.15%	330.16%	91.61%	81.70%	90.08%	81.66%	122.64%
Effective Tax Rate	37.32%	31.09%	4.50%	19.90%	0.00%	0.00%	24.22%	26.14%	20.16%	41.59%	0.00%
Return on Invested Capital (ROIC)	22.39%	25.13%	11.74%	8.80%	-5.90%	-0.53%	7.25%	18.60%	29.49%	6.78%	-4.99%
ROIC Less NNEP Spread (ROIC-NNEP)	22.09%	25.59%	11.46%	11.06%	14,679.55%	-13.27%	-359.61%	27.96%	42.74%	-15.35%	276.64%
Return on Net Nonoperating Assets (RNNOA)	-14.76%	-10.35%	-2.10%	-2.05%	-10.99%	-2.78%	8.84%	-9.68%	-6.43%	-0.91%	14.26%
Return on Equity (ROE)	7.64%	14.78%	9.64%	6.75%	-16.89%	-3.30%	16.09%	8.91%	23.06%	5.87%	9.27%
Cash Return on Invested Capital (CROIC)	-27.92%	-60.66%	19.47%	8.61%	-45.35%	9.16%	28.85%	38.64%	-59.77%	13.17%	-24.34%
Operating Return on Assets (OROA)	8.47%	12.77%	5.55%	5.10%	-4.48%	-0.43%	11.21%	7.50%	13.99%	5.64%	-3.74%
Return on Assets (ROA)	5.46%	8.69%	5.12%	3.80%	-8.97%	-1.57%	7.66%	4.06%	10.13%	2.69%	4.62%
Return on Common Equity (ROCE)	7.64%	14.78%	9.64%	6.75%	-16.89%	-3.30%	16.09%	8.91%	23.06%	5.87%	9.27%
Return on Equity Simple (ROE_SIMPLE)	6.66%	13.92%	10.24%	6.59%	-17.02%	-3.48%	14.50%	8.23%	20.33%	5.92%	8.56%
Net Operating Profit after Tax (NOPAT)	45	112	72	52	-43	-4.41	52	109	280	90	-71
NOPAT Margin	4.80%	6.56%	4.31%	3.02%	-2.66%	-0.30%	3.91%	8.10%	16.08%	6.65%	-7.41%
Net Nonoperating Expense Percent (NNEP)	0.31%	-0.46%	0.28%	-2.26%	-14,685.45%	12.74%	366.86%	-9.36%	-13.25%	22.13%	-281.63%
Cost of Revenue to Revenue	53.97%	66.02%	65.11%	69.53%	70.55%	66.23%	59.28%	54.37%	45.79%	47.17%	54.16%
SG&A Expenses to Revenue	10.55%	7.51%	9.70%	8.01%	9.45%	8.92%	9.52%	10.82%	9.68%	12.91%	16.81%
R&D to Revenue	20.34%	17.22%	18.67%	17.01%	22.28%	23.28%	22.68%	23.40%	21.11%	25.92%	35.05%
Operating Expenses to Revenue	38.37%	24.46%	30.37%	26.71%	33.25%	34.19%	35.55%	34.65%	34.07%	41.44%	56.43%
Earnings before Interest and Taxes (EBIT)	73	162	78	65	-62	-6.30	174	147	356	154	-102
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	94	275	184	159	79	122	271	316	503	312	7.60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.59	4.01	2.73	2.78	2.39	1.53	2.34	5.37	4.03	2.58	2.38
Price to Tangible Book Value (P/TBV)	5.77	9.06	5.69	4.76	12.70	7.20	5.25	54.29	73.07	24.96	9.62
Price to Revenue (P/Rev)	3.40	1.87	1.15	1.20	1.07	0.68	1.44	3.88	2.93	2.37	3.63
Price to Earnings (P/E)	68.94	28.80	26.65	42.17	0.00	0.00	16.12	65.27	19.81	43.58	27.74
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.45%	3.47%	3.75%	2.37%	0.00%	0.00%	6.20%	1.53%	5.05%	2.29%	3.61%
Enterprise Value to Invested Capital (EV/IC)	10.92	4.75	3.07	3.24	2.15	1.44	2.71	9.05	3.79	2.53	2.29
Enterprise Value to Revenue (EV/Rev)	2.93	1.77	1.08	1.11	1.16	0.78	1.30	3.55	2.99	2.40	3.73
Enterprise Value to EBITDA (EV/EBITDA)	29.46	10.97	9.85	11.99	23.84	9.41	6.41	15.03	10.34	10.42	471.01
Enterprise Value to EBIT (EV/EBIT)	38.24	18.63	23.08	29.16	0.00	0.00	9.99	32.33	14.63	21.07	0.00
Enterprise Value to NOPAT (EV/NOPAT)	61.00	27.03	25.16	36.80	0.00	0.00	33.29	43.78	18.61	36.07	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	21.07	14.81	7.04	12.47	13.06	7.43	7.84	14.89	11.25	9.81	26.34
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	15.17	37.60	0.00	14.92	8.37	21.07	0.00	18.57	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.31	0.33	0.29	0.62	0.71	0.72	0.41	0.78	0.79	0.66
Long-Term Debt to Equity	0.00	0.29	0.31	0.27	0.62	0.71	0.72	0.41	0.77	0.78	0.66
Financial Leverage	-0.67	-0.40	-0.18	-0.19	0.00	0.21	-0.02	-0.35	-0.15	0.06	0.05
Leverage Ratio	1.40	1.70	1.88	1.78	1.88	2.10	2.10	2.19	2.28	2.18	2.01
Compound Leverage Factor	1.44	1.68	1.82	1.66	2.49	6.93	1.93	1.79	2.05	1.78	2.46
Debt to Total Capital	0.00%	23.41%	25.04%	22.67%	38.19%	41.60%	41.73%	28.97%	43.67%	44.03%	39.88%
Short-Term Debt to Total Capital	0.00%	1.09%	2.00%	1.57%	0.00%	0.00%	0.00%	0.00%	0.27%	0.27%	0.25%
Long-Term Debt to Total Capital	0.00%	22.32%	23.04%	21.10%	38.19%	41.60%	41.73%	28.97%	43.40%	43.76%	39.63%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	76.59%	74.96%	77.33%	61.81%	58.40%	58.27%	71.03%	56.33%	55.97%	60.12%
Debt to EBITDA	0.00	0.88	1.28	1.36	5.68	3.84	2.16	1.25	1.95	3.13	128.01
Net Debt to EBITDA	0.00	-0.57	-0.64	-0.95	1.89	1.15	-0.65	-1.40	0.21	0.14	12.63
Long-Term Debt to EBITDA	0.00	0.84	1.18	1.27	5.68	3.84	2.16	1.25	1.94	3.11	127.22
Debt to NOPAT	0.00	2.17	3.28	4.19	-10.40	-106.19	11.23	3.63	3.51	10.85	-13.68
Net Debt to NOPAT	0.00	-1.41	-1.62	-2.91	-3.45	-31.86	-3.39	-4.07	0.38	0.48	-1.35
Long-Term Debt to NOPAT	0.00	2.07	3.02	3.90	-10.40	-106.19	11.23	3.63	3.49	10.78	-13.60
Altman Z-Score	8.45	5.02	4.53	5.12	3.24	2.82	3.61	4.00	3.85	3.18	2.75
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.92	2.05	2.22	2.55	2.61	2.88	4.41	1.50	3.03	4.89	4.19
Quick Ratio	2.52	1.62	1.72	2.01	2.08	2.20	3.93	1.35	2.59	4.22	3.68
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-57	-270	119	51	-333	77	208	226	-567	175	-347
Operating Cash Flow to CapEx	340.05%	393.26%	897.20%	486.94%	425.22%	650.63%	0.00%	1,512.80%	0.00%	972.14%	402.07%
Free Cash Flow to Firm to Interest Expense	0.00	-71.01	24.82	8.45	-15.00	3.62	9.23	7.57	-14.80	3.16	-5.31
Operating Cash Flow to Interest Expense	0.00	53.71	53.46	25.48	6.53	7.27	9.86	10.71	12.08	5.97	2.08
Operating Cash Flow Less CapEx to Interest Expense	0.00	40.05	47.50	20.25	5.00	6.16	15.30	10.00	12.73	5.36	1.56
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.11	1.34	1.18	1.34	1.18	1.01	0.86	0.68	0.68	0.50	0.35
Accounts Receivable Turnover	5.52	6.55	5.78	6.77	5.99	5.67	6.27	6.32	6.32	5.58	6.26
Inventory Turnover	7.73	10.11	7.57	8.60	8.76	6.73	6.07	7.92	6.33	4.17	4.14
Fixed Asset Turnover	13.65	16.68	14.12	15.17	14.08	13.34	14.24	15.27	22.58	20.96	13.52
Accounts Payable Turnover	5.66	7.87	6.01	7.74	7.86	7.64	9.95	9.21	6.66	6.81	7.80
Days Sales Outstanding (DSO)	66.17	55.69	63.19	53.94	60.93	64.35	58.19	57.71	57.74	65.45	58.27
Days Inventory Outstanding (DIO)	47.19	36.12	48.19	42.44	41.67	54.26	60.16	46.10	57.66	87.62	88.23
Days Payable Outstanding (DPO)	64.52	46.36	60.75	47.15	46.44	47.76	36.67	39.64	54.85	53.56	46.82
Cash Conversion Cycle (CCC)	48.84	45.45	50.63	49.23	56.15	70.84	81.68	64.17	60.56	99.51	99.68
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	254	636	588	589	879	798	642	525	1,372	1,287	1,563
Invested Capital Turnover	4.67	3.83	2.72	2.92	2.22	1.76	1.85	2.29	1.83	1.02	0.67
Increase / (Decrease) in Invested Capital	102	382	-47	1.10	290	-81	-156	-117	847	-85	276
Enterprise Value (EV)	2,772	3,022	1,807	1,907	1,893	1,146	1,738	4,753	5,206	3,251	3,580
Market Capitalization	3,220	3,179	1,924	2,058	1,744	1,005	1,915	5,195	5,101	3,208	3,484
Book Value per Share	$19.47	$21.53	$19.14	$21.58	$21.07	$19.05	$24.07	$27.48	$31.97	$31.46	$37.14
Tangible Book Value per Share	$15.49	$9.53	$9.17	$12.60	$3.97	$4.05	$10.72	$2.72	$1.76	$3.25	$9.17
Total Capital	701	1,036	941	957	1,180	1,126	1,406	1,362	2,248	2,221	2,440
Total Debt	0.00	242	236	217	451	468	587	394	982	978	973
Total Long-Term Debt	0.00	231	217	202	451	468	587	394	976	972	967
Net Debt	-447	-158	-117	-151	150	141	-177	-442	106	44	96
Capital Expenditures (CapEx)	39	52	29	31	34	24	-122	21	-25	34	34
Debt-free, Cash-free Net Working Capital (DFCFNWC)	41	81	96	129	155	149	70	-443	70	84	14
Debt-free Net Working Capital (DFNWC)	488	481	448	497	456	477	834	393	946	1,018	891
Net Working Capital (NWC)	488	469	429	482	456	477	834	393	940	1,012	885
Net Nonoperating Expense (NNE)	-1.25	1.38	-0.38	3.02	81	18	-67	29	22	17	-197
Net Nonoperating Obligations (NNO)	-447	-158	-117	-151	150	141	-177	-442	106	44	96
Total Depreciation and Amortization (D&A)	22	113	105	94	141	128	97	169	148	158	109
Debt-free, Cash-free Net Working Capital to Revenue	4.32%	4.74%	5.75%	7.50%	9.49%	10.15%	5.26%	-33.09%	4.02%	6.17%	1.48%
Debt-free Net Working Capital to Revenue	51.51%	28.22%	26.88%	28.90%	27.95%	32.41%	62.49%	29.34%	54.38%	75.12%	92.88%
Net Working Capital to Revenue	51.51%	27.56%	25.75%	28.03%	27.95%	32.41%	62.49%	29.34%	54.03%	74.67%	92.26%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.34	$2.99	$1.97	$1.40	($3.63)	($0.66)	$3.54	$2.29	$6.60	$1.86	$3.20
Adjusted Weighted Average Basic Shares Outstanding	34.76M	36.90M	36.60M	34.80M	34.20M	34.60M	33.60M	34.80M	39M	39.60M	39.20M
Adjusted Diluted Earnings per Share	$1.26	$2.84	$1.91	$1.37	($3.63)	($0.66)	$3.41	$2.08	$6.33	$1.83	$3.16
Adjusted Weighted Average Diluted Shares Outstanding	37.11M	38.90M	37.90M	35.60M	34.20M	34.60M	34.80M	38.30M	40.70M	40.20M	39.70M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.74M	36.43M	34.81M	33.70M	35.36M	32.91M	34.23M	38.85M	39.63M	38.58M	39.58M
Normalized Net Operating Profit after Tax (NOPAT)	89	99	86	66	-35	7.98	77	89	294	90	-53
Normalized NOPAT Margin	9.42%	5.80%	5.16%	3.82%	-2.14%	0.54%	5.79%	6.63%	16.92%	6.65%	-5.48%
Pre Tax Income Margin	7.86%	9.41%	4.54%	3.57%	-5.02%	-1.41%	11.95%	8.97%	18.42%	9.30%	-12.99%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	42.68	16.31	10.90	-2.79	-0.30	7.73	4.93	9.29	2.78	-1.56
NOPAT to Interest Expense	0.00	29.42	14.96	8.64	-1.95	-0.21	2.32	3.64	7.30	1.62	-1.09
EBIT Less CapEx to Interest Expense	0.00	29.03	10.35	5.67	-4.32	-1.42	13.17	4.22	9.94	2.17	-2.07
NOPAT Less CapEx to Interest Expense	0.00	15.76	9.00	3.40	-3.49	-1.33	7.76	2.94	7.95	1.01	-1.61
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	65.40%	84.35%	10.86%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	150.32%	175.27%	417.59%	191.19%	-75.42%	-517.47%	25.42%	0.00%	0.00%	249.32%	0.00%

This table displays calculated financial ratios and metrics derived from Synaptics' official financial filings.

Metric	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025
Period end date	6/25/2022	9/24/2022	12/24/2022	3/25/2023	6/24/2023	9/30/2023	12/30/2023	3/30/2024	6/29/2024	9/28/2024	12/28/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	45.33%	20.23%	-16.03%	-30.53%	-52.29%	-46.95%	-32.88%	-27.34%	8.84%	8.41%	12.74%
EBITDA Growth	39.28%	55.66%	33.33%	-64.85%	-98.65%	-103.29%	-90.77%	-97.31%	-218.18%	172.34%	133.33%
EBIT Growth	107.58%	89.58%	-45.20%	-68.66%	-126.69%	-133.94%	-145.43%	-185.66%	18.16%	19.32%	15.08%
NOPAT Growth	174.02%	31.82%	-65.88%	-79.35%	-129.79%	-135.32%	-148.68%	-193.14%	18.16%	19.32%	15.08%
Net Income Growth	360.56%	60.70%	-68.35%	-83.98%	-128.23%	-186.07%	-140.91%	-274.04%	990.17%	58.45%	120.00%
EPS Growth	353.33%	60.61%	-67.84%	-83.65%	-127.94%	-189.94%	-141.82%	-276.92%	1,026.32%	59.44%	121.74%
Operating Cash Flow Growth	47.09%	34.65%	-59.15%	-15.04%	-38.76%	-42.17%	-21.60%	-112.63%	-31.22%	-125.11%	-41.84%
Free Cash Flow Firm Growth	-606.38%	-244.72%	115.02%	112.93%	107.71%	105.06%	131.39%	-182.10%	-609.37%	-1,890.69%	-542.45%
Invested Capital Growth	161.20%	32.95%	-0.09%	-1.39%	-6.19%	-2.77%	-5.28%	1.05%	21.42%	16.98%	19.77%
Revenue Q/Q Growth	1.34%	-5.94%	-21.20%	-7.51%	-30.40%	4.58%	-0.29%	0.13%	4.26%	4.16%	3.69%
EBITDA Q/Q Growth	-14.80%	-12.01%	-45.42%	-14.10%	-96.72%	-313.64%	253.19%	63.64%	-244.44%	230.77%	394.12%
EBIT Q/Q Growth	64.06%	-27.18%	-62.01%	-30.96%	-239.71%	7.37%	49.15%	2.92%	-33.48%	8.68%	46.48%
NOPAT Q/Q Growth	41.00%	-21.87%	-63.11%	-49.20%	-303.42%	7.37%	49.15%	2.79%	-78.74%	8.68%	46.48%
Net Income Q/Q Growth	27.74%	-22.07%	-65.94%	-52.73%	-325.00%	-137.61%	83.81%	-101.11%	1,250.83%	-111.09%	107.79%
EPS Q/Q Growth	28.30%	-22.06%	-65.41%	-52.73%	-319.23%	-150.88%	83.92%	-100.00%	1,247.83%	-110.98%	108.62%
Operating Cash Flow Q/Q Growth	20.83%	-49.13%	-36.31%	117.00%	-12.90%	-51.96%	-13.66%	-134.95%	574.45%	-117.54%	300.00%
Free Cash Flow Firm Q/Q Growth	-202.56%	63.60%	109.81%	19.73%	80.38%	-76.10%	348.21%	-142.48%	-1,019.15%	15.96%	-10.74%
Invested Capital Q/Q Growth	-0.96%	1.60%	1.96%	-3.89%	-5.78%	5.31%	-0.68%	2.54%	13.21%	1.46%	1.70%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	55.86%	57.06%	52.87%	52.76%	44.52%	45.06%	45.99%	46.48%	45.84%	46.92%	45.73%
EBITDA Margin	34.09%	31.89%	22.09%	20.51%	0.97%	-1.98%	3.04%	0.76%	-1.05%	1.32%	6.29%
Operating Margin	26.05%	24.99%	13.06%	10.47%	-16.72%	-14.81%	-7.55%	-7.33%	-12.57%	-11.02%	-5.69%
EBIT Margin	29.89%	23.14%	11.16%	8.33%	-16.72%	-14.81%	-7.55%	-9.82%	-12.57%	-11.02%	-5.69%
Profit (Net Income) Margin	17.40%	14.42%	6.23%	3.18%	-10.29%	-23.39%	-3.80%	-7.63%	84.20%	-8.96%	0.67%
Tax Burden Percent	71.96%	62.30%	55.84%	38.24%	52.82%	136.95%	37.50%	77.68%	-567.57%	67.35%	-6.92%
Interest Burden Percent	80.90%	100.00%	100.00%	100.00%	116.58%	115.34%	134.08%	100.00%	118.01%	120.77%	171.05%
Effective Tax Rate	28.04%	37.70%	44.16%	61.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	34.38%	23.14%	8.96%	4.67%	-11.93%	-8.63%	-3.93%	-3.51%	-5.92%	-5.14%	-2.72%
ROIC Less NNEP Spread (ROIC-NNEP)	38.19%	14.24%	7.40%	2.71%	-7.64%	-36.75%	-1.07%	-9.74%	323.45%	-7.53%	4.15%
Return on Net Nonoperating Assets (RNNOA)	-5.75%	0.71%	1.50%	0.30%	-0.46%	-3.20%	-0.11%	-0.72%	16.67%	-0.76%	0.58%
Return on Equity (ROE)	28.63%	23.85%	10.46%	4.97%	-12.38%	-11.83%	-4.03%	-4.23%	10.75%	-5.90%	-2.14%
Cash Return on Invested Capital (CROIC)	-59.77%	-3.91%	17.59%	15.89%	13.17%	3.17%	2.55%	-6.58%	-24.34%	-20.16%	-22.35%
Operating Return on Assets (OROA)	20.45%	18.24%	7.37%	4.94%	-8.28%	-6.31%	-2.93%	-3.51%	-4.44%	-4.04%	-2.25%
Return on Assets (ROA)	11.91%	11.36%	4.11%	1.89%	-5.10%	-9.97%	-1.47%	-2.73%	29.72%	-3.29%	0.27%
Return on Common Equity (ROCE)	28.63%	23.85%	10.46%	4.97%	-12.38%	-11.83%	-4.03%	-4.23%	10.75%	-5.90%	-2.14%
Return on Equity Simple (ROE_SIMPLE)	0.00%	21.27%	18.03%	13.62%	0.00%	-3.87%	-6.36%	-8.59%	0.00%	10.77%	12.27%
Net Operating Profit after Tax (NOPAT)	89	70	26	13	-27	-25	-13	-12	-22	-20	-11
NOPAT Margin	18.75%	15.57%	7.29%	4.00%	-11.70%	-10.37%	-5.29%	-5.13%	-8.80%	-7.71%	-3.98%
Net Nonoperating Expense Percent (NNEP)	-3.81%	8.90%	1.56%	1.96%	-4.28%	28.12%	-2.86%	6.23%	-329.38%	2.39%	-6.87%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-0.57%	-	-	-	-0.48%
Cost of Revenue to Revenue	44.14%	42.94%	47.13%	47.24%	55.48%	54.94%	54.01%	53.52%	54.16%	53.09%	54.27%
SG&A Expenses to Revenue	8.04%	9.98%	12.01%	12.77%	20.33%	17.80%	16.75%	17.07%	15.68%	19.40%	18.53%
R&D to Revenue	19.75%	19.97%	25.29%	26.91%	37.18%	36.39%	34.60%	35.15%	34.11%	31.55%	31.18%
Operating Expenses to Revenue	29.81%	32.07%	39.82%	42.28%	61.24%	59.87%	53.54%	53.81%	58.41%	57.94%	51.42%
Earnings before Interest and Taxes (EBIT)	142	104	39	27	-38	-35	-18	-23	-31	-28	-15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	162	143	78	67	2.20	-4.70	7.20	1.80	-2.60	3.40	17
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.03	3.02	2.89	3.24	2.58	2.87	3.66	3.10	2.38	2.12	2.25
Price to Tangible Book Value (P/TBV)	73.07	24.76	24.98	24.70	24.96	34.79	33.50	22.99	9.62	8.02	9.85
Price to Revenue (P/Rev)	2.93	2.20	2.15	2.67	2.37	3.01	4.35	4.08	3.63	3.17	3.06
Price to Earnings (P/E)	19.81	14.66	16.66	25.06	43.58	0.00	0.00	0.00	27.74	19.65	18.32
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.05%	6.82%	6.00%	3.99%	2.29%	0.00%	0.00%	0.00%	3.61%	5.09%	5.46%
Enterprise Value to Invested Capital (EV/IC)	3.79	2.92	2.73	3.17	2.53	2.66	3.42	2.88	2.29	2.03	2.07
Enterprise Value to Revenue (EV/Rev)	2.99	2.24	2.22	2.70	2.40	3.15	4.47	4.24	3.73	3.29	3.30
Enterprise Value to EBITDA (EV/EBITDA)	10.34	7.34	6.75	9.61	10.42	23.06	58.42	320.93	471.01	205.40	131.63
Enterprise Value to EBIT (EV/EBIT)	14.63	10.05	10.41	13.83	21.07	507.35	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	18.61	13.66	15.57	21.70	36.07	724.78	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	11.25	8.42	9.44	11.05	9.81	12.07	15.99	24.06	26.34	40.77	53.11
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	15.49	19.78	18.57	82.68	130.36	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.78	0.74	0.75	0.74	0.79	0.81	0.80	0.79	0.66	0.66	0.61
Long-Term Debt to Equity	0.77	0.74	0.75	0.74	0.78	0.81	0.79	0.78	0.66	0.66	0.61
Financial Leverage	-0.15	0.05	0.20	0.11	0.06	0.09	0.10	0.07	0.05	0.10	0.14
Leverage Ratio	2.28	1.98	2.24	2.18	2.18	2.12	2.10	2.06	2.01	2.00	1.96
Compound Leverage Factor	1.84	1.98	2.24	2.18	2.54	2.45	2.82	2.06	2.37	2.41	3.36
Debt to Total Capital	43.67%	42.53%	42.97%	42.56%	44.03%	44.75%	44.41%	44.08%	39.88%	39.85%	37.69%
Short-Term Debt to Total Capital	0.27%	0.26%	0.26%	0.26%	0.27%	0.28%	0.27%	0.27%	0.25%	0.25%	0.00%
Long-Term Debt to Total Capital	43.40%	42.27%	42.71%	42.30%	43.76%	44.48%	44.13%	43.81%	39.63%	39.60%	37.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	56.33%	57.47%	57.03%	57.44%	55.97%	55.25%	55.59%	55.92%	60.12%	60.16%	62.31%
Debt to EBITDA	1.95	1.77	1.71	2.17	3.13	6.25	12.39	78.52	128.01	61.90	32.91
Net Debt to EBITDA	0.21	0.12	0.21	0.10	0.14	0.97	1.60	11.70	12.63	7.54	9.34
Long-Term Debt to EBITDA	1.94	1.76	1.70	2.16	3.11	6.21	12.31	78.04	127.22	61.52	32.91
Debt to NOPAT	3.51	3.29	3.94	4.91	10.85	196.30	-24.47	-12.82	-13.68	-14.65	-12.91
Net Debt to NOPAT	0.38	0.23	0.49	0.23	0.48	30.42	-3.16	-1.91	-1.35	-1.78	-3.67
Long-Term Debt to NOPAT	3.49	3.27	3.91	4.88	10.78	195.09	-24.32	-12.74	-13.60	-14.56	-12.91
Altman Z-Score	3.60	3.35	3.30	3.52	2.94	2.93	3.35	3.10	2.83	2.72	2.98
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.03	3.86	4.42	4.96	4.89	4.52	4.53	5.32	4.19	4.49	3.88
Quick Ratio	2.59	3.27	3.72	4.28	4.22	3.81	3.85	4.62	3.68	3.90	3.23
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-757	-276	27	32	58	14	63	-27	-297	-250	-277
Operating Cash Flow to CapEx	3,673.81%	1,453.70%	561.80%	791.97%	1,549.18%	677.61%	376.92%	-152.22%	844.16%	-125.27%	485.11%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	2.59	10.26	0.00	0.00	-42.37	-25.63
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	8.41	6.43	0.00	0.00	-1.93	2.11
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	7.17	4.72	0.00	0.00	-3.47	1.68
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.68	0.79	0.66	0.59	0.50	0.43	0.39	0.36	0.35	0.37	0.40
Accounts Receivable Turnover	6.32	6.56	6.16	6.21	5.58	5.79	5.39	5.18	6.26	7.93	7.39
Inventory Turnover	6.33	6.08	5.05	4.93	4.17	3.71	3.56	3.91	4.14	4.18	4.44
Fixed Asset Turnover	22.58	23.35	28.46	24.29	20.96	17.50	15.03	13.14	13.52	13.33	13.80
Accounts Payable Turnover	6.66	6.94	7.23	7.37	6.81	6.11	6.51	7.77	7.80	7.14	6.50
Days Sales Outstanding (DSO)	57.74	55.68	59.23	58.76	65.45	63.02	67.71	70.51	58.27	46.03	49.37
Days Inventory Outstanding (DIO)	57.66	60.08	72.22	74.09	87.62	98.33	102.46	93.41	88.23	87.22	82.24
Days Payable Outstanding (DPO)	54.85	52.59	50.47	49.55	53.56	59.71	56.10	46.97	46.82	51.09	56.15
Cash Conversion Cycle (CCC)	60.56	63.17	80.98	83.31	99.51	101.65	114.06	116.95	99.68	82.16	75.46
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,372	1,394	1,421	1,366	1,287	1,356	1,346	1,381	1,563	1,586	1,613
Invested Capital Turnover	1.83	1.49	1.23	1.17	1.02	0.83	0.74	0.68	0.67	0.67	0.68
Increase / (Decrease) in Invested Capital	847	346	-1.30	-19	-85	-39	-75	14	276	230	266
Enterprise Value (EV)	5,206	4,067	3,875	4,325	3,251	3,602	4,598	3,980	3,580	3,225	3,330
Market Capitalization	5,101	3,998	3,754	4,280	3,208	3,451	4,472	3,834	3,484	3,106	3,094
Book Value per Share	$31.97	$33.29	$32.62	$33.53	$31.46	$31.21	$31.13	$31.43	$37.14	$37.07	$34.35
Tangible Book Value per Share	$1.76	$4.06	$3.77	$4.40	$3.25	$2.57	$3.41	$4.24	$9.17	$9.78	$7.84
Total Capital	2,248	2,306	2,280	2,300	2,221	2,180	2,195	2,209	2,440	2,439	2,209
Total Debt	982	981	980	979	978	976	975	974	973	972	833
Total Long-Term Debt	976	975	974	973	972	970	969	968	967	966	833
Net Debt	106	69	121	45	44	151	126	145	96	118	236
Capital Expenditures (CapEx)	4.20	5.40	8.90	14	6.10	6.70	10	9.00	7.70	9.10	4.70
Debt-free, Cash-free Net Working Capital (DFCFNWC)	70	141	172	138	84	45	51	89	14	38	65
Debt-free Net Working Capital (DFNWC)	946	1,053	1,031	1,071	1,018	869	900	918	891	892	661
Net Working Capital (NWC)	940	1,047	1,025	1,065	1,012	863	894	912	885	886	661
Net Nonoperating Expense (NNE)	6.40	5.17	3.74	2.68	-3.20	31	-3.53	5.92	-230	3.22	-12
Net Nonoperating Obligations (NNO)	106	69	121	45	44	151	126	145	96	118	236
Total Depreciation and Amortization (D&A)	20	39	39	40	40	31	25	25	29	32	32
Debt-free, Cash-free Net Working Capital to Revenue	4.02%	7.75%	9.83%	8.57%	6.17%	3.91%	5.00%	9.48%	1.48%	3.92%	6.40%
Debt-free Net Working Capital to Revenue	54.38%	57.99%	58.97%	66.79%	75.12%	75.92%	87.51%	97.69%	92.88%	91.08%	65.44%
Net Working Capital to Revenue	54.03%	57.66%	58.63%	66.41%	74.67%	75.40%	86.92%	97.05%	92.26%	90.46%	65.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.13	$1.62	$0.55	$0.26	($0.57)	($1.43)	($0.23)	($0.46)	$5.32	($0.58)	$0.05
Adjusted Weighted Average Basic Shares Outstanding	39M	39.80M	39.80M	39.40M	39.60M	38.80M	39.20M	39.30M	39.20M	39.80M	39.70M
Adjusted Diluted Earnings per Share	$2.04	$1.59	$0.55	$0.26	($0.57)	($1.43)	($0.23)	($0.46)	$5.28	($0.58)	$0.05
Adjusted Weighted Average Diluted Shares Outstanding	40.70M	40.70M	40.20M	39.90M	40.20M	38.80M	39.20M	39.30M	39.70M	39.80M	39.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	39.63M	39.87M	39.40M	39.52M	38.58M	39.20M	39.30M	39.50M	39.58M	40.06M	39.19M
Normalized Net Operating Profit after Tax (NOPAT)	90	70	26	24	-27	-19	-12	-12	-21	-9.94	-10
Normalized NOPAT Margin	18.82%	15.57%	7.29%	7.33%	-11.70%	-8.01%	-4.90%	-5.19%	-8.40%	-3.86%	-3.77%
Pre Tax Income Margin	24.18%	23.14%	11.16%	8.33%	-19.49%	-17.08%	-10.13%	-9.82%	-14.83%	-13.31%	-9.73%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-6.52	-2.93	0.00	0.00	-4.81	-1.41
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	-4.56	-2.05	0.00	0.00	-3.37	-0.99
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-7.76	-4.64	0.00	0.00	-6.36	-1.84
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	-5.80	-3.76	0.00	0.00	-4.91	-1.42
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	4.75%	31.78%	55.64%	249.32%	0.00%	-140.46%	-78.61%	0.00%	0.00%	44.11%

Frequently Asked Questions About Synaptics' Financials

When does Synaptics's fiscal year end?

According to the most recent income statement we have on file, Synaptics' financial year ends in June. Their financial year 2024 ended on June 29, 2024.

How has Synaptics' net income changed over the last 10 years?

Synaptics' net income appears to be on an upward trend, with a most recent value of $125.60 million in 2024, rising from $46.70 million in 2014. The previous period was $73.60 million in 2023. See Synaptics' forecast for analyst expectations on what’s next for the company.

What is Synaptics's operating income?

Synaptics's total operating income in 2024 was -$101.60 million, based on the following breakdown:

Total Gross Profit: $439.80 million
Total Operating Expenses: $541.40 million

How has Synaptics revenue changed over the last 10 years?

Over the last 10 years, Synaptics' total revenue changed from $947.50 million in 2014 to $959.40 million in 2024, a change of 1.3%.

How much debt does Synaptics have?

Synaptics' total liabilities were at $1.36 billion at the end of 2024, a 0.7% decrease from 2023, and a 325.6% increase since 2014.

How much cash does Synaptics have?

In the past 10 years, Synaptics' cash and equivalents has ranged from $301 million in 2018 to $924.70 million in 2023, and is currently $876.90 million as of their latest financial filing in 2024.

How has Synaptics' book value per share changed over the last 10 years?

Over the last 10 years, Synaptics' book value per share changed from 19.47 in 2014 to 37.14 in 2024, a change of 90.8%.

Related Companies

This page (NASDAQ:SYNA) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synaptics (SYNA) Financials

Frequently Asked Questions About Synaptics' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synaptics (SYNA) Financials

Annual Income Statements for Synaptics

Quarterly Income Statements for Synaptics

Annual Cash Flow Statements for Synaptics

Quarterly Cash Flow Statements for Synaptics

Annual Balance Sheets for Synaptics

Quarterly Balance Sheets for Synaptics

Annual Metrics and Ratios for Synaptics

Quarterly Metrics and Ratios for Synaptics

Frequently Asked Questions About Synaptics' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools